LAVIPHARM S.A.
Announcement of Regulated Information
Lavipharm S.A. announces that Mr. Christodoulos Maniatis son of Periklis, Group Chief Financial Officer, sold 2.071 common Lavipharm shares, amounting to 9.153,82 Euros, on Tuesday, December 11, 2007 and 9.400 common Lavipharm shares, amounting to 37.688,00 Euros, on Wednesday, December 12, 2007.